Vitamin D Treatment to Patients Suffering From Chronic Pain and Vitamin D Hypovitaminosis
NCT ID: NCT01023490
Last Updated: 2012-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2010-01-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain
NCT01417923
Supplementation With Vitamin D3 on Chronic Low Back Pain Patient
NCT06082375
An Intervention Study to Investigate the Effect of B-vitamin Supplementation for 2-years on Bone Health
NCT03892395
Chronic Pain and Vitamin D
NCT02002000
Association of Vitamin D Intake, and Associated Factors with Low Back Pain: a Retrospective Cohort Study
NCT06765382
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Vitamin D is naturally produced by skin exposed to ultraviolet B. Despite the fact that Israel is a sunny country, a majority of all patients, and particularly those with pain, have inadequate intake of vitamin D.
Vitamin D therapy is easy for patients to self administer, well tolerated, and very economical.
In this study, we'll check whether vitamin D will lead to a decrease in pain intensity in patients suffering from chronic low back pain.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Placebo
Placebo
Vitamin D
34,500 IU vitamin D per week
Vitamin D
34,5000 IU vitamin D per week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D
34,5000 IU vitamin D per week
Placebo
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tel Aviv Sourasky Medical Center, Pain Medicine Unit
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TASMC-09-SB-0494-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.